Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages

Cancer Research

Volumn 58, Issue 4, 1998, Pages 717-723

  Suh, Nanjoo ^a   Honda, Tadashi ^b   Finlay, Heather J ^b   Barchowsky, Aaron ^a   Williams, Charlotte ^a   Benoit, Nicole E ^a   Xie, Qiao Wen ^c   Nathan, Carl ^c   Gribble, Gordon W ^b   Sporn, Michael B ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Dartmouth College ^*  (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; NITRIC OXIDE SYNTHASE; OLEANOLIC ACID; TRITERPENOID; URSOLIC ACID;

ANIMAL CELL; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CYCLIZATION; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; GENE TARGETING; MACROPHAGE ACTIVATION; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; ENZYME INHIBITORS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OLEANOLIC ACID; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; TRITERPENES;

EID: 17144439794     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Hong, W. K., and Sporn, M. B. Recent advances in chemoprevention of cancer. Science (Washington DC), 278: 1073-1077, 1997.
2. Spom, M. B., and Roberts, A. B. Peptide growth factors and inflammation, tissue repair, and cancer. J. Clin. Invest., 78: 329-332, 1986.
3. Ohshima, H., and Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res., 305: 253-264, 1994.
4. Marnett, L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
5. Moncada, S., Palmer, R. M. J., and Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43: 109-141, 1991.
6. Anggard, E. Nitric oxide: mediator, murderer, and medicine. Lancet, 343: 1199-1206, 1994.
7. Nathan, C. F., and Xie, Q. W. Nitric oxide synthases: roles, tolls, and controls. Cell, 78: 915-918, 1994.
8. Seibert, K., and Masferrer, J. Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor, 94: 17-23, 1994.
9. Salvemini, D., Seibert, K., Masferrer, J. L., Misko, T. P., Currie, M. G., and Needleman, P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest., 93: 1940-1947, 1994.
10. Tamir, S., and Tannenbaum, S. R. The role of nitric oxide (NO) in the carcinogenic process. Biochim. Biophys. Acta, 1288: F31-F36, 1996.
11. Chhatwal, V. J. S., Ngoi, S. S., Chan, S. T. F., Chia, Y. W., and Moochhala, S. M. Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa and surrounding peritumoral normal mucosa. Carcinogenesis (Lond.), 15: 2081-2085, 1994.
12. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
13. Eberhart, C. E., and DuBois, R. N. Eicosanoids and the gastrointestinal tract. Gastroenterology, 109: 285-301, 1995.
14. Cobbs, C. S., Brenman, J. E., Aldape, K. D., Bredt, D. S., and Israel, M. A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res., 55: 727-730, 1995.
15. Misko, T. P., Trotter, J. L., and Cross, A. H. Mediation of inflammation by encephalitogenic cells: Interferon γ induction of nitric oxide synthase and cyclooxygenase 2. J. Neuroimmunol., 61: 195-204, 1995.
16. Simonian, N. A., and Coyle, J. T. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol., 36: 83-106, 1996.
17. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colon tumors. Gastroenterology, 110: 1259-1262, 1996.
18. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
19. Takahashi, M., Fukuda, K., Ohata, T., Sugimura, T., and Wakabayashi, K. Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res., 57: 1233-1237, 1997.
20. O'Banion, M. K., Winn, V. D., and Young, D. A. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA, 89: 4888-4892, 1992.
21. Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q. W., and Nathan, C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J. Exp. Med., 178: 605-613, 1993.
22. Nathan, C. F., and Xie, Q. W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem., 269: 13725-13728, 1994.
23. Perrella, M. A., Yoshizumi, M., Fen. Z., Tsai, J. C., Hsieh, C. M., Kourembanas, S., and Lee, M. E. Transforming growth factor-β1, but not dexamethasone, down-regulates nitric oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells. J. Biol. Chem., 269: 14595-14600, 1994.
24. Reddy, S. T., Gilbert, R. S., Xie, W., Luner, S., and Herschman, H. R. TGF-β1 inhibits both endotoxin-induced prostaglandin synthesis and expression of the TIS10/ prostaglandin synthase 2 gene in mutine macrophages. J. Leukocyte Biol., 55: 192-200, 1994.
25. Kunz, D., Walker, G., Eberhardt, W., and Pfeilschifter, J. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1β-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc. Natl. Acad. Sci. USA, 93: 255-259, 1996.
26. Huang, M. T., Ho, C. T., Wang, Z. Y., Ferraro, T., Lou, Y. R., Stauber, K., Ma, W., Georgiadis, C., Laskin, J. D., and Conney, A. H. Inhibition of skin tumorigenesis by rosemary and its constituents carnesol and ursolic acid. Cancer Res., 54: 701-708, 1994.
27. Nishino, H., Nishino, A., Takayasu, J., Hasegawa, T., Iwashima, A., Hirabayashi, K., Iwata, S., and Shibata, S. Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds. Cancer Res., 48: 5210-5215, 1988.
28. Hirota, M., Mori, T., Yoshio, M., and Iriye, R. Suppression of tumor promoter-induced inflammation of mouse ear by ursolic acid and 4,4-dimethylcholestane derivatives. Agric. Biol. Chem., 54: 1073-1075, 1990.
29. Singh, G. B., Singh, S., Bani, S., Gupta, B. D., and Banerjee, S. K. Anti-inflammatory activity of oleanolic acid in rats and mice. J. Pharm. Pharmacol., 44: 456-458, 1992.
30. Honda, T., Finlay, H. J., Gribble, G. W., Suh, N., and Sporn, M. B. New enone derivatives of oleanolic acid and ursolic acid as inhibitors of nitric oxide production in mouse macrophages. Bioorg. Med. Chem. Lett., 7: 1623-1628, 1997.
31. Bogdan, C., Paik, J., Vodovotz, Y., and Nathan, C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem., 267: 23301-23308, 1992.
32. Ding, A., Nathan, C. F., Graycar, J., Derynck, R., Stuehr, D. J., and Srimal, S., Macrophage deactivating factor and transforming growth factors-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol., 145: 940-944, 1990.
33. Xie, Q. W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., and Nathan, C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science (Washington DC), 256: 225-228, 1992.
34. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
35. Salvemini, D., Misko, T. P., Masferrer, J. L., Seibert, K., Currie, M. G., and Needleman, P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA, 90: 7240-7244, 1993.
36. Barchowsky, A., Dudek, E. J., Treadwell, M. D., and Wetterhahn, K. E. Arsenic induces oxidant stress and NF-κB activation in cultured aortic endothelial cells. Free Radical Biol. Med., 21: 783-790, 1996.
37. Masferrer, J. L., Zweifel, B. S., Seibert, K., and Needleman, P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J. Clin. Invest., 86: 1375-1379, 1990.
38. Gilbert, R. S., and Herschman, H. R. "Macrophage" nitric oxide synthase is a glucocorticoid-inhibitable primary response gene in 3T3 cells. J. Cell. Physiol., 157: 128-132, 1993.
39. Collart, M. A., Baeuerle, P., and Vassalli, P. Regulation of tumor necrosis factor α transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol., 10: 1498-1506, 1990.
40. Xie, Q. W., Kashiwabara, Y., and Nathan, C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem., 269: 4705-4708, 1994.
41. Jin, F-y., Nathan, C., Radzioch, D., and Ding, A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell, 88: 417-426, 1997.
42. Kapil, A., and Sharma, S. Effect of oleanolic acid on complement in adjuvant- and carrageenan-induced inflammation in rats. J. Pharm. Pharmacol., 47: 585-587, 1995.
43. Xie, W., Merrill, J. R., Bradshaw, W. S., and Simmons, D. L. Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch. Biochem. Biophys., 300: 247-252, 1993.
44. Roshak, A. K., Jackson, J. R., McGough, K., Chabot-Fletcher, M., Mochan, E., and Marshall, L. A. Manipulation of distinct NFκB proteins alters interleukin-1β-induced human rheumatoid synovial fibroblast prostaglandin E2 formation. J. Biol. Chem., 271: 31496-31501, 1996.
45. Barnes, P. J., and Karin, M. Nuclear factor-κB-a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 336: 1066-1071, 1997.
46. Crofford, L. J., Tan. B., McCarthy, C. J., and Hla, T. Involvement of nuclear factor κB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheumat., 40: 226-236, 1997.
47. Schmedtje, J. F., Jr., Ji, Y. S., Liu, W. L., DuBois, R. N., and Runge, M. S. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem., 272: 601-608, 1997.
48. Radomski, M. W., Palmer, R. M., and Moncada, S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA, 87: 10043-10047, 1990.
49. Prescott, S. M., and White, R. L. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell, 87: 783-786, 1996.
50. Hooper, D. G., Bagasra, O., Marin, J. C., Zborek, A., Ohnishi, S. T., Kean, R., Champion, J. M., Sarker, A. B., Bobroski, L., Farber, J. L., Akaike, T., Maeda, H., and Koprowski, H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA, 94: 2528-2533, 1997.
51. Hantraye, P., Brouillet, E., Ferrante, R., Palfi, S., Dolan, R., Matthews, R. T., and Beal, M. F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced Parkinsonism in baboons. Nat. Med., 2: 1017-1021, 1996.
52. Goodwin, J. L., Uemura, E., and Cunnick, J. E. Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ. Brain Res., 692: 207-214, 1995.
53. Good, P. F., Werner, P., Hsu, A., Olanow, C. W., and Perl, D. P. Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol., 149: 21-28, 1996.
54. Frölich, J. C. A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol. Sci., 18: 30-34, 1997.